PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 215 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $164,833 | -30.0% | 19,740 | +11.4% | 0.00% | -50.0% |
Q2 2023 | $235,588 | +52.8% | 17,713 | +33.1% | 0.00% | +100.0% |
Q1 2023 | $154,144 | +146703.8% | 13,311 | +3.9% | 0.00% | – |
Q4 2022 | $105 | -99.9% | 12,811 | -6.6% | 0.00% | -100.0% |
Q3 2022 | $80,000 | +19.4% | 13,711 | -9.6% | 0.00% | 0.0% |
Q2 2022 | $67,000 | -62.4% | 15,169 | -22.4% | 0.00% | 0.0% |
Q1 2022 | $178,000 | -55.4% | 19,546 | +0.3% | 0.00% | -66.7% |
Q4 2021 | $399,000 | -3.6% | 19,487 | +20.4% | 0.00% | 0.0% |
Q3 2021 | $414,000 | -28.6% | 16,187 | -2.4% | 0.00% | -40.0% |
Q2 2021 | $580,000 | -0.2% | 16,587 | -4.9% | 0.01% | -16.7% |
Q1 2021 | $581,000 | +50.5% | 17,438 | +17.1% | 0.01% | +50.0% |
Q4 2020 | $386,000 | +173.8% | 14,886 | +4.0% | 0.00% | +100.0% |
Q3 2020 | $141,000 | +513.0% | 14,320 | +118.1% | 0.00% | – |
Q2 2020 | $23,000 | -55.8% | 6,565 | -34.4% | 0.00% | -100.0% |
Q3 2019 | $52,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madrone Advisors, LLC | 16,415,933 | $137,073,041 | 29.47% |
ORACLE INVESTMENT MANAGEMENT INC | 1,638,395 | $13,680,598 | 4.20% |
Decheng Capital Management III (Cayman), LLC | 1,463,872 | $12,223,331 | 4.08% |
VK Services, LLC | 2,632,784 | $21,983,746 | 2.93% |
Iron Triangle Partners LP | 1,800,000 | $15,030,000 | 2.20% |
BOURNE LENT ASSET MANAGEMENT INC | 574,350 | $4,795,822 | 2.11% |
Deep Track Capital, LP | 6,000,000 | $50,100,000 | 1.93% |
Jackson Square Partners, LLC | 6,933,865 | $57,897,773 | 1.93% |
ARK Investment Management | 29,822,440 | $249,017,370 | 1.90% |
Nikko Asset Management Americas, Inc. | 13,447,666 | $112,153,534 | 1.34% |